Andrea Tarr BPharm MSC MRPharmS, the founder and director of Veterinary Prescriber said: "Prescribing is a neglected aspect of veterinary practice. When it comes to making treatment decisions, vets are very poorly supported by their professional organisations, the pharmaceutical industry has a hugely distorting influence and there's a lack of access to really helpful information.
"We're determined to use the expertise in Veterinary Prescriber to change this, and support vets in their use of medicines in the best interests of animals, their owners and the environment.
"With this in mind, we start the year with a learning module of good veterinary dispensing practice."
The module explains what constitutes a well-run dispensary, including how to organise, handle and store medicines correctly. It reviews the legal classifications of medicines, including controlled drugs and the cascade. It also considers why dispensing errors occur and what to do when they happen.
Veterinary Prescriber says its modules are evidence-based, peer-reviewed and independent of the pharmaceutical industry.
Subscription costs £9.95 per month, which you can cancel any time. To subscribe, visit: www.veterinaryprescriber.org
Pets At Home Vet Group and Dick White Referrals have announced a strategic partnership in order to develop Pets at Home's strategy for providing specialist care.
Pets at Home says it is creating a new divisional structure comprised of the existing First Opinion Division (Vets4Pets and Companion Care joint venture practices) and the new Specialist Division, which comprises Dick White Referrals, Northwest Surgeons, Anderson Moores, and Eye Vet Referrals.
Dick White has been appointed Clinical Director of the new Specialist Division.
Dick will remain as a shareholder in Dick White Referrals. He and three of the Specialist clinicians - Giunio Bruto Cherubini, Federico Corletto and Rob Foale - will retain 24% of the practice.
Sally Hopson, CEO of Pets at Home Vet Group said: "We are delighted to have attracted a colleague of Dick White’s pedigree to join us, not only to help drive the future growth of Dick White Referrals, but also to play a key role in developing our Specialist Division. Professor White is a key figure in the development of the Specialist Veterinary segment; he has trained many of the leading Specialist veterinary practitioners. This is a tremendous step forward for the Vet Group. I’m also very pleased that Professor White and his colleagues have chosen to remain as equity partners in Dick White Referrals."
Dick said: "Forming this strategic partnership provides great opportunities for us to continue to develop Dick White Referrals as a world class referrals centre with a team of leading Veterinary Specialists. I am delighted to be working with a partner that shares our vision for Dick White Referrals and is committed to supporting its future development. Joining the Board of the Specialist Division will allow me to provide clinical leadership and governance across the division, input into the formulation of strategy and support M&A activity and veterinary recruitment."
The company says that despite the development of alternatives to natural bone grafting, such as allografts and synthetic products, autologous bone graft is still considered the standard. However, it has a number of disadvantages, such as donor site morbidities and lameness, limited availability of graft volume (particularly in small size pets) and additional surgical time.
Biocera-Vet is a new bone substitute indicated in surgical procedures where bone grafting is necessary, such as arthrodesis, complex fractures, corrective osteotomy used in correction of limb deformities or as add-on to Tibial Tuberosity Advancement (TTA).
Biocera-Vet is an injectable synthetic self-hardening calcium-phosphate cement combining osteo-inductive, osteo-conductive and osteo-integrative properties designed to support a fast and strong consolidation.
TheraVet says Biocera-Vet also presents an excellent safety profile thanks to its biocompatibility, reduced comorbidities and superior ergonomics which save a significant amount of surgical time.
Dr Olivier Stiévenart, an orthopaedic veterinary surgeon at Surgivet in Belgium said: "Using Biocera-Vet has enabled us to optimise our patient care considerably, by reducing the operating time by at least 30 minutes. The use of an efficient and rapid bone substitute represents a real progress in terms of both operations and the animal’s quality of life".
Julie Schurgers, Chief Commercial Officer of TheraVet, said: "Biocera-Vet is a unique product on the veterinary bone substitute market, combining outstanding bone consolidation properties with an excellent safety profile and superior ergonomics. We are very excited today to announce its commercialisation on the market and are convinced that this innovative product will significantly improve the daily practices of veterinarians, for the well-being of patients and their owners."
The product is now available in Belgium, and will be rolled out in France and the Netherlands shortly, with the rest of Europe following later in 2021 / 2022.
For more information, visit: https://www.thera.vet/en/biocera-vet
Charcovet Gel contains 30g of activated charcoal in a 60ml syringe.
Dr John Henderson, Large Animal Product Manager at Forte Healthcare said: “In young animals with digestive disturbances, Charcovet Gel uses the adsorbent properties of activated charcoal to support the gut in a return to normal function.
"The value of using activated charcoal in cases of digestive upset in young animals has long been recognised, but the difficulty and mess involved in mixing such a fine dry powder in water presented considerable usability issues.
"With Charcovet Gel, the appropriate volume of activated charcoal gel is simply selected from the graduated syringe and administered directly into the animal’s mouth.
"Charcovet Gel can be given daily as needed to support the animal during the period of digestive upset.”
Each box of Charcovet Gel contains 12 syringes.
Charcovet Gel is available now from all major veterinary wholesalers, or directly from Forte Healthcare Ltd.
For more information contact your Forte Territory Manager, email enquiries@fortehealthcare.com or visit: https://www.fortehealthcare.com/product/charcovet-gel
Dilaterol is an oral syrup containing 25 mgs/ml clenbuterol hydrochloride, indicated to treat respiratory disease in horses. It causes intense bronchodilation, inhibits histamine release and increases ciliary mucous clearance. It can be used as a frontline or adjuvant therapy.
Dilaterol is administered via food and comes in a 355 ml bottle with a pump dispenser for easy and accurate dosing.
Emma Jennings, Equine Brand Manager at Dechra said: “We are very pleased to have added Dilaterol to our comprehensive range of equine therapies as it is an established and effective treatment for bronchial conditions.
"It is particularly useful in cases of respiratory allergy, bronchospasm and equine asthma and is already regarded as a valuable tool for veterinary professionals."
Dilaterol will be available to order through wholesalers. For more information, visit www.dechra.co.uk.
The ten-minute online survey aims to gather a snapshot of horse health over the period of a week.
The results help to identify trends in endemic equine diseases and help the Blue Cross steer equine awareness, education and research.
This year the survey includes some welfare questions to help guide knowledge in response to what the charity calls 'the UK’s horse welfare crisis'.
The National Equine Health Survey is run by the Blue Cross in partnership with the British Equine Veterinary Association. Dodson and Horrell is helping to cover the costs of running the scheme.
Supporters of the survey include the British Horse Society, Horse Trust, Redwings and the Pony Club.
Medal-winning riders Mary and Emily King, and Yazmin Pinchen (pictured right) also support the survey.
Visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk to register and take part, which carries the chance of winning prizes including Star Lister Clippers, a Lister Adagio Trimmer and some Burford Ariat boots.
MSD says the new vaccine reduces the clinical signs of respiratory disease and viral shedding from infection with Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3V), and that no other UK-licensed BRD vaccine can be administered earlier in life.
According to the company, it also delivers the fastest on-farm protection, with an onset of immunity after administration of 5 days for BRSV and 7 days for Pi3V. The duration of immunity is 12 weeks for both viruses.
MSD Animal Health ruminant veterinary adviser Dr Kat Baxter-Smith MRCVS said: "Early-age protection of calves through intranasal vaccination can help prevent pneumonia and positively impact a calf’s productive future.
"The sooner and faster these young calves can be protected against viral BRD and the permanent lung damage it causes, the better their potential lifetime productivity, be it in terms of delivering expected milk yield in the dairy herd or growth performance on the beef unit1 2."
Kat added that Bovilis Intranasal RSP Live also activates non-specific immunity – stimulating receptors and cytokines in the innate immune system3: "This equates to protection against viral replication in the nasopharyngeal cavity, reduction of virus shedding and protection of the calf against subsequent clinical symptoms3."
MSD says a practical benefit of Bovilis Intranasal RSP Live to farmers is that it can be used on farm up to six hours after mixing with the solvent, which is the longest of all the available intranasal BRD vaccines. Additionally, the new vaccine is supplied as a farm-friendly, easy-to administer nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility a new easy-clean injector and nozzle kit is available for farmers needing to vaccinate multiple animals.
References:
AceSedate for horses contains 10mg/ml acepromazine as its active ingredient, which the company says means a lower dose volume is required compared to the non-UK licensed equine acepromazine options available.
The dosage of AceSedate is 0.03-0.10 mg per kg bodyweight, however Jurox recommends that the lower end of the dose range is always selected where possible. It can be administered via intramuscular or slow intravenous injection.
AceSedate is supplied in a multidose vial and the shelf life after opening the immediate packaging is 28 days.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "The launch of AceSedate means injectable acepromazine is now licensed in the UK for horses, giving vets peace-of-mind that a licensed product is now available. It is a welcome addition to our equine anaesthesia, analgesia and sedation portfolio."
For more information, visit: www.jurox.com/uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail customerservice@jurox.co.uk.
Two winners will be flown from a London airport to spend 2 nights at the Krka Terme Hotel Svoboda Strunjan, a night at the Grand Union Hotel Ljubljana and a night at the Grand Hotel Bled, plus car hire.
To enter, visit www.discoverkrka.co.uk and pick out the differences between the Dalmations.
Ned Flaxman from Krka said: "I’ve only recently joined KRKA and I’m sure like many people I imagined Slovenia to be some far-off country in Eastern Europe. But it’s much closer than you might think - being only a couple hour’s boat ride from Venice.
"I would urge anyone to enter the competition to be in with the chance of winning this truly memorable trip. From the cliffs and stunning beaches of Strunjan to the lively and beautiful city of Ljubljana, Slovenia is a hidden gem just waiting to be discovered."
The paper was written by FEDIAF’s Scientific Advisory Board, comprised of independent academics from leading European universities, with the aim of informing both the industry and the public.
Based on recent scientific data, the paper explains the different life expectancies of dogs related to their size, and defines when "old age" sets in. It explains how changes in the digestive tract can affect food intake, how food texture may become a crucial factor, and how aging can lead to changes in energy metabolism and alter the nutrient requirements of senior dogs. It also offers practical guidance to pet owners for feeding an older dog.
Dr Thomas Brenten, Chairman of FEDIAF’s Nutrition & Analytical Science Group said: "Age-related changes in cognitive functions, behaviour, skin, digestive tract, cardiovascular system, respiratory tract, degenerative joint and skeletal function, as well as urinary disorders are the most common issues concerning older dogs. Many of these can be addressed via nutrition."
The paper can be downloaded in the new section on science on FEDIAF’s website: https://tinyurl.com/fediaf-senior-dogs.
In the UK, the product is marketed under the brand names Vetofol and Inductofol.
An issue of coring has been reported, where the shearing off of a portion of the 20mm bromobutyl bung occurs as the vial is pierced to withdraw the product. This may result in particles from the bung entering the product and potentially being drawn up into the syringe upon extraction of the product from the vial. It may also result in the bung not resealing fully after use.
If you have any queries in relation to the recall or require details of the product in other markets, contact Mrs Deborah Curran Tel. +4428 30264435 or email deborah.curran@norbrook.co.uk.
According to the AHT, there is undisputed evidence that owners, riders and trainers have a poor ability to recognise signs of pain seen when horses are ridden. As a result, problems are labelled as training-related, rider-related, behavioural, or deemed 'normal' for that horse because 'that’s how he’s always gone'.
This, says the AHT, means pain-related problems are often disregarded, the horse continues in work, and the problem gets progressively worse.
Dr Sue Dyson, Head of Clinical Orthopaedics at the AHT, believes it may be easier to educate riders and trainers to recognise changes in facial expression and behaviour rather than lameness. So she and her team set out to develop and test an ethogram to describe facial expressions in ridden horses and to determine whether individuals could interpret and correctly apply the ethogram consistently.
At this stage in the project, they concluded that their ethogram could reliably be used to describe facial expressions of ridden horses by people from different professional backgrounds (full paper here: http://www.journalvetbehavior.com/article/S1558-7878(16)30184-8/fulltext).
In the next stage of the project, Sue and her team sought to demonstrate that the ethogram could be used to identify lameness.
The ethogram was applied blindly by a trained analyst to photographs (n=519) of the head and neck of lame (n=76) and non-lame (n=25) horses acquired during ridden schooling-type work at both trot and canter. These included images of seven lame horses acquired before (n=30 photographs) and after diagnostic analgesia had abolished lameness (n=22 photographs).
A pain score (0-3; 0=normal, 1-3=abnormal) was applied to each feature in the ethogram, based on published descriptions of pain in horses.
A total of 27,407 facial markers were recorded, with those giving the greatest significant difference between lame and sound horses including ears back, eyes partially or fully closed, an open mouth with exposed teeth and being severely above the bit.
Pain scores were higher for lame horses than non-lame horses (p<0.001). Total pain score (p<0.05), total head position score (p<0.01), and total ear score (p<0.01) were reduced in lame horses after abolition of lameness.
Severely ‘above the bit’, twisting the head, asymmetrical position of the bit, ear position (both ears backwards, one ear backwards and one to the side, one ear backwards and one ear forwards) and eye features (exposure of the sclera, the eye partially or completely closed, muscle tension caudal to the eye, an intense stare) were the best indicators of pain.
The researchers concluded that application of the ethogram and pain score could differentiate between lame and non-lame horses. Assessment of facial expression could potentially improve recognition of pain-related gait abnormalities in ridden horses (full paper here: http://www.journalvetbehavior.com/article/S1558-7878(17)30019-9/fulltext)
Sue and her team are now working on the development of a whole horse ethogram and its application to non-lame and lame horses, to help to differentiate between manifestations of conflict behaviour, in response to the demands of the rider, and pain. They are also working towards the development of a practical tool for recognising facial expressions, similar to that of a body condition score chart, which they say could dramatically improve the health and welfare of all horses.
Photo: Signs of pain include ears back (pain score of 3), intense stare, muscle tension and mouth. Courtesy Dr Sue Tyson.
Feliscratch by Feliway is a synthetic copy of the feline interdigital semiochemical (FIS) naturally produced by cats and Ceva says it is the only product clinically proven to help divert scratching behaviour onto a desired location.
The company says it helps control both vertical and horizontal scratching and helps prevent inappropriate scratching with newly adopted cats or kittens.
The new pheromone is available in a pack of nine single use 5ml pipettes which should be applied on a scratching post to redirect the scratching.
The product attracts cats in three ways: the blue staining mimics the visual message (scratch marks), catnip helps attract the cat to the scratching post and the pheromone directs cat scratching on the surface where the product has been applied. One pack lasts for up to four weeks.
Feliscratch by Feliway can be used alongside Feliway Classic if the owner is experiencing stress-related scratching or alongside Feliway Friends for conflicts in the home.
Claire Russell, pheromone product manager at Ceva Animal Health said: "Scratching is a major problem in cat owning households with many owners experiencing damaged carpets, sofas and other household furniture. Feliscratch by Feliway can help redirect scratching onto a desired location, such as a scratching post, and can be used in conjunction with Feliway Classic and Feliway Friends to help prevent other stress-related behaviours."
Ceva Animal Health has launched a range of marketing materials to support the launch of Feliscratch by Feliway including a pet owner leaflet, posters, wobblers and a digital pack containing social media posts, product pack shots, logo and videos.
For information on Feliway visit www.feliway.com/uk.
Additional credit is given if the display includes a den, and the top ten displays win a luxury chocolate hamper.
Ceva says the aim of the exercise is to highlight preventative steps pet owners can take to manage their pets' firework fears and the benefits of building a den to help calm and reassure dogs during the firework festivities,
Claire Russell, pheromone product manager at Ceva Animal Health, said: "Our display competition is one of the highlights of the veterinary practice year with veterinary professionals creating innovative displays that capture the imagination of their clients and help educate them on the preventative measures that they can adopt at home to help manage their pet’s firework fears."
Ceva has a range of marketing materials for veterinary practices to use in the competition, including waiting room materials.
For further information, contact your local Ceva territory manager.
Amongst the speakers were Catherine Oxtoby MRCVS, Risk Manager at the Veterinary Defence Society, and Dr Huw Stacey, director of clinical services at Vets4Pets.
Dr Stacey explained how Vets4Pets and Companion Care practices are embracing a culture of sharing information when things don’t go according to plan in practice.
He said: "We all face challenges in the workplace, and this event focused on how different professions can share ideas and good practice and how they find solutions to any challenges.
"The culture of aviation and maritime is one of minimising risk and putting safety first, and it is fascinating to compare their approach to that found in medicine and veterinary.
"One common theme we discussed was the wellbeing of both professionals and patients or clients, with tiredness being at the top of the list of things that can negatively affect wellbeing and performance.
"Both aviation and maritime recognised that long shifts, particularly overnight, needed to be reduced in order to improve the outcome for everyone.
"In veterinary and human medicine, tiredness and long shifts are often worn as a badge of honour and being tired at work was something that should be admired, rather than addressed.
"But, tired vets are effectively neglecting themselves and their own wellbeing, which in turn leads to pets not receiving the best level of care in practice.
"This is something we’re taking seriously at Vets4Pets and Companion Care, and we’re currently looking at ways to decrease the risk of overworked and tired vets and vet nurses."
Another area of discussion was around the reporting of near misses and when things don’t go right, and how veterinary professionals need to identify and share the learnings from these events, not only within their practice, but with the wider profession too.
He said: "We need to continually emphasise the concept of a ‘just’ culture, to ensure our colleagues feel confident about reporting incidents open and honestly."
"It is not in the interests of the professional, the patient or the client to bottle things up, and at Vets4Pets and Companion Care we’re encouraging all of our practices to adopt the VDS VetSafe system, which provides a mechanism for sharing incident reports across the profession, enabling us all to learn from them to the benefit of our patients."
Zoetis says that the problem appears not to be an endemic wellbeing issue for which the answer might be to develop greater individual resilience, but rather it is a symptom of the working environment itself, fuelled by structural, cultural and economic factors.
This, the company argues, means that concentrating on individual resilience may be misguided, and a new approach is needed, one that addresses the environmental factors at play.
The white paper identifies three areas for change:
Firstly, a complete reimagining of the veterinary workplace with more flexible and sustainable working models.
This includes considering more flexible work rotas, using technology to ease workloads, and enhancing the supporting role of veterinary nurses.
Indeed the most important factor in improving workplace wellbeing and professional satisfaction, cited by 27% of vets, was to better train veterinary nurses to take on more responsibility.
Secondly, finding ways to adapt to meet growing and varied client needs.
The white paper recommends enhancing communication training, adopting technology for better client management, and offering more support for vets when managing emotionally challenging conversations with clients.
Finally, the paper calls for a rethink over how vets are selected for in the first place.
Currently, the profession draws from a pool of 96% white, 29% fee-paying, largely female people who are not representative of the market they serve.
Greater diversity in the profession, Zoetis says, delivers social benefits, strategic advantages and workplaces with broader perspectives and greater psychological safety.
Stephanie Armstrong, Regional President at Zoetis, said: “Addressing retention in the veterinary field requires looking beyond individual well-being to systemic factors.
"By fostering better work environments and providing support, we can help ensure that veterinarians continue to provide vital services to our communities.”
Zoetis is urging stakeholders across the veterinary and animal health sector to review the white paper’s insights and join a collective effort to implement solutions.
https://www2.zoetis.co.uk/about-zoetis/news-media/knowledge-hub/transforming-veterinary-practice-for-the-21st-century
Dechra Veterinary Products has launched a new online fluid therapy distance-learning course for vets and nurses, to help maximise the potential of its Vetivex® fluids range.
The Fluids Knowledge Programme has been created to provide comprehensive and flexible online CPD for companion animal and equine practitioners. The coursework, which counts for six to eight hours of CPD learning, includes the latest thinking from fluid therapy specialists Dr Ava Firth, Karen Humm and Kevin Corley.
Dechra says the course combines theoretical and practical advice on fluid therapy for both small animals and horses, and can be used for training, as a refresher, and to develop thinking on fluid therapy. Self-assessment questions included within the course allow progress to be monitored throughout.
Gwenda Bason, marketing director for Dechra Veterinary Products, said: "We've spent months of research and development producing this online learning portal for professionals. It will enable vets and nurses to improve their knowledge, understanding and patient care. Being online, users can dip in and out of it as and when their schedules allow and additional costs often associated with CPD learning, such as travel or accommodation costs, are eliminated.
"When practices choose Vetivex, they're not just buying bags of fluid, they're benefitting from our investment in practice education which will improve their understanding of the role and management of fluids."
Dechra estimates the programme is worth around £400 per person, and therefore offers savings of over £3000 in CPD costs for an 8 member practice.
To find out more about the Fluids Knowledge Programme visit www.fluidtherapy.co.uk, or contact Liz Rawlings at Dechra on 01743 441 632.
Mr Seymour-Hamilton was removed from the Register after his Kent practice was found to have unhygienic and unsterile conditions as well as poor record keeping, although he has always disputed this, maintaining that he was not actually practising at the time of the inspection.
Mr Seymour-Hamilton made an application for restoration on the basis that he did not want to be restored to the Register in order to practise veterinary surgery, but so that he could more easily achieve recognition from academics and drug companies for his work on herbal and natural remedies.
Mr Seymour-Hamilton's dispute over the original findings of the 1994 case was ruled inadmissible.
In considering his application, the Committee took into account the fact that he had not accepted the original findings from 1994 nor had he, over the course of his various applications for restoration, shown any insight into his original conduct or the serious concerns about his fitness to practice raised in previous restoration hearings.
It also considered that Mr Seymour-Hamilton had been off the Register for 29 years and would need to have demonstrated prolonged, intensive and formal training to ensure he met the Day One Competences required of a veterinary surgeon.
The College submitted that he had made no such attempts and so would pose a significant risk to animal health and welfare if he were allowed to practice again.
The Committee also considered that Mr Seymour-Hamilton had indicated that he had practised veterinary surgery while off the Register – including conducting two spay procedures in Calais, France – and had used his own animals to try out new and untested ‘herbal remedies’.
The College submitted that this indicated someone who didn’t have due regard to the importance of the current level of skills, experience and qualifications required in order to undertake veterinary surgery competently, and therefore posed a risk to animal health and welfare.
Dr Kathryn Peaty MRCVS, chairing the Committee and speaking on its behalf, said: “The College invited the Committee to consider that where, as here, some 29 years have passed since this veterinary surgeon has practised, there has been no intensive, and prolonged re-training, no acceptance of the original findings and no insight into concerns about his fitness to practise, there will inevitably be a serious risk to the welfare of animals and the wider public interest if the applicant is restored to the Register.
The Committee agrees, and considers that the applicant has not shown the required insight as to the steps he needs to take to return to safe veterinary practice.”
Accordingly, the Committee decided that it would not be in the public interest to restore Mr Seymour-Hamilton to the Register.
www.rcvs.org.uk/disciplinary
Tim was the principal veterinary surgeon at Nine Mile Veterinary Group in Wokingham, Berkshire, from its opening in 1985. He grew the business from one vet and three staff to 16 vets and 60 staff, before selling to CVS in 2007.
Thereupon he became the National Veterinary Director for CVS, supporting the business as it grew from 200 to 1200 vets and supporting individual vets and practices with management advice and clinical practice.
In more recent times Tim has been working with a peripatetic surgery group.
Tim has worked at Guide Dogs before: between 1987 and 2007, he was a Centre Veterinary Advisor at the charity’s now-closed site in Wokingham.
Tim said: “Guide dogs are fantastic to work with – they are good-natured and easy to handle, and the owners always have the best interests of the dog at heart. Plus, you know you are helping more than someone’s pet, a working dog making a real difference to a person’s life. A guide dog needs to be happy and healthy to fulfil its role. It all adds up to a very different flavour of vet work.
“I am looking forward to being back, but in a more central role with more strategic responsibility. The veterinary world has changed so much, even in the last ten years, and it will be good to draw on my experiences to help Guide Dogs traverse that change.
“It’s important that we keep the healthcare of guide dogs at the top of the priorities list; the dogs have always been at the very core of the charity. It’s crucial that we have solid relationships with veterinary practices, to ensure our dogs receive the greatest care at the best value to the charity."
The study looked at the anonymised employment data of 1,642 veterinary nurses working across 418 UK primary-care companion animal veterinary practices at the end of 2020, including both qualified and student nurses.
Of these, 278 (16.9%) nurses resigned from their veterinary practice between 1 January to 31 December 2021.
Career progression was cited as a reason for resigning by 36.7%, compared to 12.9% for personal reasons, 11.9% for better pay, 10.1% for a better work-life balance, 6.8% to relocate, and 3.6% decided not to return after parental leave.
The research also looked at factors associated with lower odds of future nurse resignations.
They included longer employment tenure (p < 0.001) and working at practices with greater property and facilities ratings (p < 0.049).
Head nurses and students were least likely to resign, whereas by comparison, the nurse role was associated with resignations (p = 0.008), adding to the evidence to support nursing career pathways.
The employee engagement metric, eNPS, was also identified as a reliable indicator of nurse retention. reflecting similar findings in other healthcare professions.
Imogen Schofield, Veterinary Statistician and Epidemiologist at CVS, said: “We want to support the whole industry in reducing the number of nurses leaving their roles and the profession.
"Little objective industry data is available on the true reasons behind nurse attrition and we believe this is the first study to outline the risk factors for nurse resignations using practice data, providing an important addition to the evidence-base surrounding this complex topic.
“Reflecting on our research, that was based on data in 2021, we have since seen our attrition rate fall and our employee engagement measure increase as we have focused on developing career pathways, empowering nurses to take on more responsibilities; developing a range of wellbeing programmes, launching a variety of colleague benefits, and significantly investing in our practices.”
Reference
RSPCA has launched a new website called 'Political Animal' to encourage voters to lobby their prospective parliamentary candidates about animal welfare issues ahead of the General Election.
The site offers an interesting timeline of the last 20 years of animal welfare law, leading up to the Animal Welfare Act 2006, showing landmark changes. It also gives details of the RSPCA's stance on issues like status dogs, higher welfare farming, wild animals in circuses and animals used in experiments.
RSPCA parliamentary officer Stacey Frier, said: "The Political Animal microsite is a unique project allowing our supporters to drive the debate by letting politicians know what they want them to do for animal welfare if they are elected.
"The RSPCA and its supporters have been instrumental in campaigning for change in animal welfare legislation since the Society's creation in 1824 and we're urging the incoming parliament to continue to work with us to achieve further animal welfare milestones."
For more information, please log on to http://www.politicalanimal.org.uk/
The practice was formed earlier this year by Jade Statt and Sam Joseph, two veterinary surgeons who, quite separately, had been inspired by the bond between homeless people and their dogs and decided to do what they could to help. Each hit the streets, Jade in Westminster and Sam in North London, offering healthchecks and basic flea and worm treatment to the homeless. Unbeknownst to each other, they worked under the same name of Streetvet.
Their paths crossed earlier this year, whereupon they decided to join forces and create a proper framework through which to deliver not just preventative care for the majority of animals that are well cared for and healthy, but treatment for those that need it. So Streetvet was born.
Since then, the practice has grown to a 65-strong team of volunteer veterinary surgeons and nurses providing a free, first opinion veterinary service across London, supported by drug companies, veterinary practices, animal welfare charities, social non-profit organisations and local councils.
Jade said: "We have vets out in the community at least 4 days a week and everything that can be done in a consultation room, we can perform on the street. This includes medicating, vaccinating, blood sampling, urine analysis, lump sampling, microchipping and more.
"When we meet a dog that needs more advanced treatment we are able to take them to one of the practices that we work at to perform procedures including neutering, dental work, surgery, diagnostic imaging and even hydrotherapy.
"Being vets, we love animals, but much of our day-to-day work involves caring for their owners as well. Many of the owners that we meet are vulnerable people and one of the main benefits of having vets out on the streets is that we get to know the owners and their dogs and gain their trust.”
Streetvet will be launching in Brighton on Sunday 26th November and in Bristol on 2nd December.
if you are in the Brighton or Bristol area and want to volunteer, offer practice support or get involved with fundraising, email: info@streetvet.co.uk.
Veterinary professionals across the UK are also encouraged to email their interest in volunteering, to help StreetVet build its database and in time set up StreetVet UK-wide.
The new service is led by Virginia Crespo DVM PGDip MSc MRCVS and Alex Hamilton BA VetMB MRCVS, pictured right.
Virginia qualified in 2012 from the Autonomous University of Barcelona, where she also served a rotating internship before completing an internship in neurology and neurosurgery at the Animal Health Trust in 2016. She finished a three-year residency in neurology and neurosurgery at Langford Veterinary Services in July, alongside attaining a Master’s of Science degree with Bristol University.
Alex graduated from Cambridge University in 2005 and after five years working in both mixed and emergency and critical care practice, he completed a surgical internship at the Animal Referral Hospital, Sydney, in 2012. He then completed a European accredited neurology residency at Melbourne University and Willows Veterinary Centre, in Solihull, and has since worked in Australia and the UK as a neurologist.
Clinical director Duncan Barnes said: “We’re delighted to welcome Virginia and Alex to Eastcott to lead this new service.
"They will provide in-depth consultations and neurological assessments alongside a variety of advanced diagnostic procedures to identify the problem and prepare an appropriate treatment plan.
"Virginia and Alex will have access to Eastcott’s new 1.5T MRI scanner and the clinic’s CT scanner, as well as electromyography, to assess the function of the nerves and muscles, and cerebrospinal fluid analysis.
"They will also work closely with another new recruit, Nicholas Taylor, who has joined us as referral radiographer, and other specialists across the hospital as part of a holistic approach to patient care."
For more information visit www.eastcottreferrals.co.uk.
Animalcare Ltd has launched Tilmodil (tilmicosin 300mg/ml solution for injection), a semi-synthetic macrolide antibiotic licensed for pneumonia in cattle and sheep, foul in the foot in cattle, and footrot and mastitis in sheep.
According to the company, Tilmicosin is fast-acting1, long-acting2 and highly effective against the major Gram-ve bovine respiratory pathogens.2,3 In addition, the company says tissue penetration is excellent.1 In calves a single SC injection at 10mg/kg bw results in lung concentrations exceeding the MIC90 of Mannheimia haemolytica for 72 hours.2
Animalcare says that pooled data from greater than 6000 cattle has confirmed the effectiveness of tilmicosin in the treatment of bovine respiratory disease (BRD) in well-controlled, randomised field studies. Tilmodil treatment has been proven equally effective compared to antibiotics, such as florfenicol, marbofloxacin and danofloxacin.
A recent report by the Farm Animal Welfare Council estimates that three million of the national sheep flock are lame at any one time. It is estimated that footrot is responsible for greater than 90% of lameness and is present in 97% of flocks. Tilmicosin has good activity against the key Gram-ve pathogens2 and has been successfully used in the treatment of footrot.4
Tilmodil has been developed for animal use only and is administered by veterinary surgeons only. Dosage is 1ml per 30kg bw for respiratory disease and mastitis in sheep and 0.5ml per 30kg bw for interdigital necrobacillosis (foul in the foot/footrot/bovine pododermatitis).
Tilmodil is administered as a single, low volume subcutaneous (SC) injection dose and presented in 50ml multi-dose vials.
References
1. Apley M., Antimicrobial therapy of Bovine Respiratory Disease.Veterinary Clinics of North America.Food Animal Practice (1997) 13,3:159-5622. Tilmodil SPC3. Giguere S et al .,Antimicrobial therapy in Veterinary Medicine.4th edition 2006.Chp.12,2014. Winter A., Lameness in sheep. 2. Treatment and control. In Practice (2004),3, 130-139.